中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Design and synthesis of guaianolide-germacranolide heterodimers as novel anticancer agents against hepatocellular carcinoma

文献类型:期刊论文

作者Yan,Jia-Xin; Li,Qi-Hao; Li,Tian-Ze; Huang,Zhi-Yan; Ma,Yun-Bao; Chen,Ji-Jun
刊名DRUG DEVELOPMENT RESEARCH
出版日期2023
关键词antihepatoma effects guaianolide-germacranolide heterodimers PDGFRA DERIVATIVES
ISSN号1098-2299
DOI10.1002/ddr.22087
英文摘要Inspired by our previous finding that disesquiterpenoids showed more potent antihepatoma cytotoxicity than their corresponding parent monomers, natural product-like guaianolide-germacranolide heterodimers were designed and synthesized from guaianolide diene and germacranolides via a biomimetic Diels-Alder reaction to provide three antihepatoma active dimers with novel scaffolds. To explore the structure-activity relationship, 31 derivatives containing ester, carbamate, ether, urea, amide, and triazole functional groups at C-14 & PRIME; were synthesized and evaluated for their cytotoxic activities against HepG2, Huh7, and SK-Hep-1 cell lines. Among them, 25 compounds were more potent than sorafenib against HepG2 cells, 15 compounds were stronger than sorafenib against Huh7 cells, and 17 compounds were stronger than sorafenib against SK-Hep-1 cells. Compound 23 showed the most potent cytotoxicity against three hepatoma cell lines with IC50 values of 4.4 & mu;M (HepG2), 3.7 & mu;M (Huh7), and 3.1 & mu;M (SK-Hep-1), which were 2.7-, 2.2-, and 2.8-fold more potent than sorafenib, respectively. The underlying mechanism study demonstrated that compound 23 could induce cell apoptosis, prevent cell migration and invasion, cause G2/M phase arrest in SK-Hep-1 cells. Network pharmacology analyses predicted PDGFRA was one of the potential targets of compound 23, and surface plasmon resonance (SPR) assay verified that 23 had strong affinity with PDGFRA with a dissociatin constant (KD) value of 90.2 nM. These promising findings revealed that structurally novel guaianolide-germacranolide heterodimers might provide a new inspiration for the discovery of antihepatoma agents.
学科主题Pharmacology & Pharmacy
WOS记录号WOS:001013790700001
源URL[http://ir.kib.ac.cn/handle/151853/75318]  
专题中国科学院昆明植物研究所
推荐引用方式
GB/T 7714
Yan,Jia-Xin,Li,Qi-Hao,Li,Tian-Ze,et al. Design and synthesis of guaianolide-germacranolide heterodimers as novel anticancer agents against hepatocellular carcinoma[J]. DRUG DEVELOPMENT RESEARCH,2023.
APA Yan,Jia-Xin,Li,Qi-Hao,Li,Tian-Ze,Huang,Zhi-Yan,Ma,Yun-Bao,&Chen,Ji-Jun.(2023).Design and synthesis of guaianolide-germacranolide heterodimers as novel anticancer agents against hepatocellular carcinoma.DRUG DEVELOPMENT RESEARCH.
MLA Yan,Jia-Xin,et al."Design and synthesis of guaianolide-germacranolide heterodimers as novel anticancer agents against hepatocellular carcinoma".DRUG DEVELOPMENT RESEARCH (2023).

入库方式: OAI收割

来源:昆明植物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。